[4-[5-(2-Fluoro-5-methyl-4-thiophen-3-ylphenyl)-1,2,4-oxadiazol-3-yl]-2-(hydroxymethyl)phenyl]methanol | 1192548-83-6

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 英文名称: [4-[5-(2-Fluoro-5-methyl-4-thiophen-3-ylphenyl)-1,2,4-oxadiazol-3-yl]-2-(hydroxymethyl)phenyl]methanol
• CAS: 1192548-83-6
• 化学式: C₂₁H₁₇FN₂O₃S
• 分子量: 396.442
• InChiKey: ZWBAFWKBYJIBJS-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.5
• 重原子数：
  28
• 可旋转键数：
  5
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.14
• 拓扑面积：
  108
• 氢给体数：
  2
• 氢受体数：
  7

文献信息

• AMINO ACID COMPOUNDS
  申请人：Ohmori Yutaka

  公开号：US20090298894A1

  公开（公告）日：2009-12-03

  [Problem] To provide novel compounds that are S1P1 receptor agonists and exhibit an immunosuppressive activities by inducing lymphocyte sequestration in secondary lymphoid tissues. In addition, to provide a pharmaceutical agent which comprises the compounds as an effective component, in particular to provide a therapeutic and/or prophylactic agent for an autoimmune disease and the like. [Solving Means] Amino acid compounds that are represented by the following Formula (1) are provided

  提供一种新型化合物，它们是S1P1受体激动剂，并通过在次级淋巴组织中诱导淋巴细胞滞留而表现出免疫抑制活性。此外，提供一种包含这些化合物作为有效成分的药物制剂，特别是提供用于自身免疫疾病等疾病的治疗和/或预防药物。提供以下Formula (1)所代表的氨基酸化合物。